Neuraxis Inc (NRXS) is now in the Overvalued zone, suggesting that its current forward PS ratio of 8.48 is considered Overvalued compared with the five-year average of -17.01. The fair price of Neuraxis Inc (NRXS) is between 2.88 to 4.68 according to relative valuation method. Compared to the current price of 5.89 USD , Neuraxis Inc By Overvalued By 25.87%.

Relative Value

Fair Zone

2.88-4.68

Current Price：5.89

25.87%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Neuraxis Inc (NRXS) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Neuraxis Inc (NRXS) has a current Price-to-Book (P/B) ratio of 19.33. Compared to its 3-year average P/B ratio of 2.47, the current P/B ratio is approximately 681.64% higher. Relative to its 5-year average P/B ratio of 2.47, the current P/B ratio is about 681.64% higher. Neuraxis Inc (NRXS) has a Forward Free Cash Flow (FCF) yield of approximately -13.22%. Compared to its 3-year average FCF yield of -32.71%, the current FCF yield is approximately -59.58% lower. Relative to its 5-year average FCF yield of -32.71%, the current FCF yield is about -59.58% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for NRXS competitors is 14.82, providing a benchmark for relative valuation. Neuraxis Inc Corp (NRXS.A) exhibits a P/S ratio of 8.48, which is -42.76% above the industry average. Given its robust revenue growth of 21.72%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of NRXS increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of NRXS in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NRXS currently overvalued or undervalued?

What is Neuraxis Inc (NRXS) fair value?

NRXS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Neuraxis Inc (NRXS) is between 2.88 to 4.68 according to relative valuation method.

How does NRXS's valuation metrics compare to the industry average?

The average P/S ratio for NRXS's competitors is 14.82, providing a benchmark for relative valuation. Neuraxis Inc Corp (NRXS) exhibits a P/S ratio of 8.48, which is -42.76% above the industry average. Given its robust revenue growth of 21.72%, this premium appears sustainable.

What is the current P/B ratio for Neuraxis Inc (NRXS) as of Mar 04 2026?

As of Mar 04 2026, Neuraxis Inc (NRXS) has a P/B ratio of 19.33. This indicates that the market values NRXS at 19.33 times its book value.

What is the current FCF Yield for Neuraxis Inc (NRXS) as of Mar 04 2026?

As of Mar 04 2026, Neuraxis Inc (NRXS) has a FCF Yield of -13.22%. This means that for every dollar of Neuraxis Inc's market capitalization, the company generates -13.22 cents in free cash flow.

What is the current Forward P/E ratio for Neuraxis Inc (NRXS) as of Mar 04 2026?

As of Mar 04 2026, Neuraxis Inc (NRXS) has a Forward P/E ratio of -6.66. This means the market is willing to pay $-6.66 for every dollar of Neuraxis Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Neuraxis Inc (NRXS) as of Mar 04 2026?

As of Mar 04 2026, Neuraxis Inc (NRXS) has a Forward P/S ratio of 8.48. This means the market is valuing NRXS at $8.48 for every dollar of expected revenue over the next 12 months.

NRXS Valuation